SCHEMBL8099591

SCHEMBL8099591

NC1CCN(CCN2CCOCC2)CC1.NC1CCN(CCN2CCOCC2)CC1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
GNAI3 P08754 1/20 0.48
GNAO1 P09471 1/20 0.48
GNAI1 P63096 1/20 0.48
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 1/20 0.46
GLA P06280 1/20 0.42
CYP1A2 P05177 2/20 0.40
DPP4 P27487 1/20 0.39
SPHK1 Q9NYA1 1/20 0.39
CYP2D6 P10635 1/20 0.39
HPGD P15428 1/20 0.38
DUSP3 P51452 1/20 0.38
USP2 O75604 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6942281 1.00 KEAP1 (0.52) KEAP1SMN1; SMN2GNAI3GNAO1GNAI1
SCHEMBL23273615 0.88 KEAP1 (0.40) KEAP1SMN1; SMN2GNAI3GNAO1GNAI1
SCHEMBL7485372 0.86 KEAP1 (0.59) KEAP1SMN1; SMN2GNAI3GNAO1GNAI1
SCHEMBL18933322 0.81 GNAI3 (0.42) KEAP1SMN1; SMN2GNAI3GNAO1GNAI1
SCHEMBL6946272 0.80 GNAI3 (0.52) GNAI3GNAO1GNAI1ALDH1A1CYP1A2
Cyclooctanamine SCHEMBL7481924 0.80 KEAP1 (0.52) KEAP1SMN1; SMN2KDM4EALDH1A1GLA
SCHEMBL235080 0.79 KDM4E (0.65) KEAP1SMN1; SMN2KDM4EALDH1A1GLA
SCHEMBL27838638 0.78 ALDH1A1 (0.43) KEAP1SMN1; SMN2ALDH1A1GLA
SCHEMBL2761704 0.78 GNAI3 (0.50) GNAI3GNAO1GNAI1ALDH1A1CYP1A2
SCHEMBL2761795 0.78 GNAI3 (0.50) GNAI3GNAO1GNAI1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056744-A1 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES Aventis Pharmaceuticals Inc. (US) 2000-12-06 EP disclosed
WO-1999043675-A1 6,9-DISUBSTITUTED 2-[TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES AVENTIS PHARMACEUTICALS INC. (US) 1999-09-02 WO disclosed